Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
United Health Products Provides Update on FDA PMA Application Process
March 29, 2023
Via
NewMediaWire
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Tickers
UEEC
Find Balance with Nootropa: Premium Products to Support the Mind-Body-Soul Journey
March 28, 2023
Via
Get News
Exposures
Product Safety
Millburn Laser Center Receives New Accure Acne Laser Treatment
March 28, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Revolutionary Red Light Therapy Beds Launched By Spectra Red Light
March 28, 2023
Via
Get News
Exposures
Product Safety
OKYO Pharma To Begin Phase 2 Efficacy Trials For Dry Eye Disease Drug Candidate In March 2023, Anticipates Releasing Topline Results By Q4
March 28, 2023
Via
TheNewswire.com
Exposures
Product Safety
Tickers
OKYO
South Beach Skinlab Introduces South Beach Skincare Repair & Release Cream
March 27, 2023
Via
Press Advantage
Exposures
Product Safety
Real-Time FDA Data Source On Biotech Stocks For Independent Investors Launched
March 27, 2023
Via
Press Release Distribution Service
Exposures
Product Safety
Arbutus Medical Launches TrakPak® with QuikBow™ to Improve Skeletal Traction, Announces Successful Cases
March 29, 2023
Via
PRLog
Exposures
Product Safety
E-Cigarette Company: Let’s get compliant!
March 28, 2023
Via
TimesNewswire
Exposures
Product Safety
3N Eye Care Introduces the Revolutionary Eye Contact Lenses Cleaner for Dry Eye Relief
March 27, 2023
Via
TimesNewswire
Exposures
Product Safety
Creative Biolabs’ Services and Products Exclusively for Aptamer Therapeutics
March 27, 2023
Via
Get News
Exposures
Product Safety
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Files Patent for Treatment of Fibromyalgia
March 27, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Tickers
SILO
Neosho Allergen-Free Honey Product Manufacturer: Safety Practice Report Released
March 27, 2023
Via
Press Release Distribution Service
Exposures
Product Safety
New Results Medical Weight Loss Offers Game-Changing Semaglutide for Weight Loss in Mesa and Scottsdale, AZ
March 25, 2023
Via
Syndication Cloud
Exposures
Product Safety
Applied UV's Devices Effective Against Dangerous Pathogen Candida Auris As CDC Warns Of Rapid Spread In US Healthcare Facilities
March 24, 2023
Via
News Direct
Exposures
Product Safety
Tickers
AUVI
Applied UV's Devices Effective Against Dangerous Pathogen Candida Auris As CDC Warns Of Rapid Spread In US Healthcare Facilities
March 24, 2023
Via
TheNewswire.com
Exposures
Product Safety
Tickers
AUVI
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Schedules Conference Call/Webinar to Review FY 2022 Results, Discuss Corporate Updates
March 23, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
PCSA
InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Provides Statement Regarding FDA Initiative to Accelerate Approval Process for Gene Therapies
March 23, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
GNPX
Jonathon’s ICL Experience Shared By Waite Vision
March 22, 2023
Via
Press Advantage
Exposures
Product Safety
89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)
March 22, 2023
Via
Spotlight Growth
Exposures
Product Safety
Tickers
ETNB
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
March 22, 2023
Via
TheNewswire.com
Exposures
Product Safety
Tickers
BMY
GILD
JNJ
PFE
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
March 22, 2023
Via
News Direct
Exposures
Product Safety
Tickers
BMY
GILD
JNJ
PFE
A marathon, not a sprint: Life with chronic myeloid leukemia
March 21, 2023
Via
Brandpoint
Exposures
Product Safety
Why did Sarepta Therapeutics Stock Plummet?
March 21, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
BMRN
FGEN
PFE
PTC
Kirkman CEO Eric Gripentrog Named CEO of the Year
March 21, 2023
Via
Newsfile
Exposures
Product Safety
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Rebrands, Including Changing Name to IGC Pharma, as Part of ‘Major Milestone’ Alignment
March 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
IGC
Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
March 21, 2023
Via
PRLog
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) to Provide Clinical Trial Updates at Emerging Growth Conference
March 20, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
QSAM
Kadimastem Earns FDA Approval of its IND Application For its US Multi-Site Phase IIa Clinical Trial of AstroRx® to Treat ALS
March 20, 2023
Via
TheNewswire.com
Exposures
Product Safety
Kadimastem Earns FDA Approval of its IND Application For its US Multi-Site Phase IIa Clinical Trial of AstroRx® to Treat ALS
March 20, 2023
Via
News Direct
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.